{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:40:42Z","timestamp":1773380442457,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/aci.0b013e3283551da5","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T11:49:48Z","timestamp":1337773788000},"page":"421-426","source":"Crossref","is-referenced-by-count":42,"title":["Update on systemic therapies for atopic dermatitis"],"prefix":"10.1097","volume":"12","author":[{"given":"Kristopher S.","family":"Denby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors.","volume":"2","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(04)16808-6","article-title":"Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.","volume":"364","author":"Remuzzi","year":"2004","journal-title":"Lancet"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2010.04.027","article-title":"Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.","volume":"64","author":"Haeck","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"946048","DOI":"10.1155\/2012\/946048","article-title":"Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.","volume":"2012","author":"Ogata","year":"2012","journal-title":"Int J Rheumatol"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2011.09.009","article-title":"Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection.","volume":"128","author":"Navarini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/bmj.301.6746.268","article-title":"Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.","volume":"301","author":"Hansen","year":"1990","journal-title":"BMJ"},{"key":"R9-14-20210128","first-page":"14","article-title":"Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial.","volume":"19","author":"Sood","year":"2000","journal-title":"Indian J Gastroenterol"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2133.2002.04989.x","article-title":"Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.","volume":"147","author":"Berth-Jones","year":"2002","journal-title":"Br J Dermatol"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780150207","article-title":"Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression.","volume":"15","author":"Lipsmeyer","year":"1972","journal-title":"Arthritis Rheum"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.4.5633.746","article-title":"Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.","volume":"4","author":"Doak","year":"1968","journal-title":"Br Med J"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.1969.03150210077009","article-title":"Disseminated visceral Kaposis sarcoma: appearance after human renal homograft operation.","volume":"207","author":"Siegel","year":"1969","journal-title":"JAMA"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk.","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","article-title":"The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules.","volume":"114","author":"Johnston","year":"2005","journal-title":"Clin Immunol"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2011.03.024","article-title":"A randomized trial of methotrexate versus azathioprine for severe atopic eczema.","volume":"128","author":"Schram","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-199243010-00008","article-title":"Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease.","volume":"43","author":"Todd","year":"1992","journal-title":"Drugs"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(05)82557-0","article-title":"Recombinant human interferon gamma therapy for osteopetrosis.","volume":"121","author":"Key","year":"1992","journal-title":"J Pediatr"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1525-1470.2010.01356.x","article-title":"The clinical spectrum and therapeutic challenge of eczema herpeticum.","volume":"28","author":"Frisch","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.0307-6938.2001.00955.x","article-title":"A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis.","volume":"27","author":"Jolles","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.aller.2011.04.007","article-title":"Experience with intravenous immunoglobulin in severe childhood atopic dermatitis.","volume":"40","author":"Ozen","year":"2012","journal-title":"Allergol Immunopathol (Madr)"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4168\/aair.2011.3.2.89","article-title":"Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis.","volume":"3","author":"Jee","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00592-011-0276-y","article-title":"The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.","volume":"48","author":"Fidan","year":"2011","journal-title":"Acta Diabetol"},{"key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archdermatol.2007.22","article-title":"A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis.","volume":"144","author":"Behshad","year":"2008","journal-title":"Arch Dermatol"},{"key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaci.2010.10.043","article-title":"Peroxisome proliferator-activated receptor gamma-mediated suppression of dendritic cell function prevents the onset of atopic dermatitis in NCTnd mice.","volume":"127","author":"Jung","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1194\/jlr.R800001-JLR200","article-title":"Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology.","volume":"49","author":"Schmuth","year":"2008","journal-title":"J Lipid Res"},{"key":"R30-14-20210128","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/jid.2011.144","article-title":"Efficacy of combined peroxisome proliferator-activated receptor-alpha ligand and glucocorticoid therapy in a murine model of atopic dermatitis.","volume":"131","author":"Hatano","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R31-14-20210128","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(00)05114-X","article-title":"Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial.","volume":"357","author":"Reynolds","year":"2001","journal-title":"Lancet"},{"key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0190-9622(98)70123-9","article-title":"High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.","volume":"38","author":"Krutmann","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R34-14-20210128","first-page":"727","article-title":"Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis J Eur Acad Dermatol V","volume":"25","author":"Pavlovsky","year":"2011","journal-title":"enereol"},{"key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1468-3083.2010.03857.x","article-title":"A first prospective randomized controlled trial on the efficacy and safety of synchronous balneophototherapy vs. narrow-band UVB monotherapy for atopic dermatitis.","volume":"25","author":"Heinlin","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R36-14-20210128","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.","volume":"128","author":"Tintle","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/000155502762064575","article-title":"Heliotherapy in atopic dermatitis: a prospective study on climatotherapy using the SCORAD index.","volume":"82","author":"Autio","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2133.2008.08518.x","article-title":"Heliotherapy improves vitamin D balance and atopic dermatitis.","volume":"158","author":"Vahavihu","year":"2008","journal-title":"Br J Dermatol"},{"key":"R39-14-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2010.04663.x","article-title":"Full-spectrum light phototherapy for atopic dermatitis.","volume":"50","author":"Byun","year":"2011","journal-title":"Int J Dermatol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e3283551da5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:50:53Z","timestamp":1636563053000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201208000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e3283551da5","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}